Literature DB >> 19260098

Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children.

Arthur K Liu1, Nicholas K Foreman, Laurie E Gaspar, Elizabeth Trinidad, Michael H Handler.   

Abstract

BACKGROUND: Treatment failure in children with ependymoma is relatively common, with the majority of events consisting of local failure. Salvage therapy for these children historically had poor results, with repeated local recurrences. To improve these outcomes, we began to offer hypofractionated re-irradiation after resection at first local recurrence. To minimize the duration of therapy, we chose a hypofractionated regimen that has been shown to be well tolerated in adult patients. PROCEDURE: We performed a review of the experience at the Children's Hospital in Denver and at the Department of Radiation Oncology at the University of Colorado Denver from 1995 to 2008 with hypofractionated re-irradiation after maximally safe resection in children with locally recurrent ependymoma.
RESULTS: Six children with locally recurrent ependymoma were seen in that time period. After maximally safe resection, all six received hypofractionated radiation therapy of 24-30 Gy delivered in three fractions. With a median follow-up of 28 months from the time of re-irradiation, all six children are alive with no evidence of disease. Three children had evidence of radiation necrosis, either clinically or based on imaging, but none required significant intervention.
CONCLUSIONS: Hypofractionated re-irradiation after resection for locally recurrent ependymoma is well tolerated. This approach also appears to provide good local control. Additional follow-up is required to determine the efficacy and potential late effects of hypofractionated re-irradiation in this patient population. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19260098     DOI: 10.1002/pbc.21982

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  15 in total

Review 1.  The role of stereotactic radiotherapy in the management of ependymomas.

Authors:  Mark D Krieger; J Gordon McComb
Journal:  Childs Nerv Syst       Date:  2009-04-09       Impact factor: 1.475

2.  Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy.

Authors:  Melis Gultekin; Mustafa Cengiz; Duygu Sezen; Faruk Zorlu; Ferah Yildiz; Gozde Yazici; Pervin Hurmuz; Gokhan Ozyigit; Fadil Akyol; Murat Gurkaynak
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

Review 3.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

4.  Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.

Authors:  Tejpal Gupta; Madan Maitre; Priyamvada Gupta; Rahul Krishnatry; Abhishek Chatterjee; Aliasgar Moiyadi; Prakash Shetty; Vikas Singh; Girish Chinnaswamy; Sridhar Epari; Ayushi Sahay; Vijay Patil; Jayant GodaSastri
Journal:  J Neurooncol       Date:  2020-02-18       Impact factor: 4.130

5.  Fractionated stereotactic radiosurgery for recurrent ependymoma in children.

Authors:  Lindsey M Hoffman; S Reed Plimpton; Nicholas K Foreman; Nicholas V Stence; Todd C Hankinson; Michael H Handler; Molly S Hemenway; Rajeev Vibhakar; Arthur K Liu
Journal:  J Neurooncol       Date:  2014-01       Impact factor: 4.130

6.  Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy.

Authors:  Taro Murai; Kengo Sato; Michio Iwabuchi; Yoshihiko Manabe; Hiroyuki Ogino; Hiromitsu Iwata; Koshi Tatewaki; Naoki Yokota; Seiji Ohta; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2015-12-18       Impact factor: 2.374

7.  Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

Authors:  Maura Massimino; Rosalba Miceli; Felice Giangaspero; Luna Boschetti; Piergiorgio Modena; Manila Antonelli; Paolo Ferroli; Daniele Bertin; Emilia Pecori; Laura Valentini; Veronica Biassoni; Maria Luisa Garrè; Elisabetta Schiavello; Iacopo Sardi; Armando Cama; Elisabetta Viscardi; Giovanni Scarzello; Silvia Scoccianti; Maurizio Mascarin; Lucia Quaglietta; Giuseppe Cinalli; Barbara Diletto; Lorenzo Genitori; Paola Peretta; Anna Mussano; Annamaria Buccoliero; Giuseppina Calareso; Salvina Barra; Angela Mastronuzzi; Carlo Giussani; Carlo Efisio Marras; Rita Balter; Patrizia Bertolini; Ermanno Giombelli; Milena La Spina; Francesca R Buttarelli; Bianca Pollo; Lorenza Gandola
Journal:  Neuro Oncol       Date:  2016-05-18       Impact factor: 12.300

Review 8.  Multidisciplinary management of pediatric intracranial ependymoma.

Authors:  David B Mansur
Journal:  CNS Oncol       Date:  2013-05

Review 9.  Management strategies for recurrent ependymoma in the paediatric population.

Authors:  M Sangra; N Thorp; P May; B Pizer; C Mallucci
Journal:  Childs Nerv Syst       Date:  2009-05-30       Impact factor: 1.475

Review 10.  EANO guidelines for the diagnosis and treatment of ependymal tumors.

Authors:  Roberta Rudà; Guido Reifenberger; Didier Frappaz; Stefan M Pfister; Anne Laprie; Thomas Santarius; Patrick Roth; Joerg Christian Tonn; Riccardo Soffietti; Michael Weller; Elizabeth Cohen-Jonathan Moyal
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.